Biotech 2050 Podcast

Biotech 2050 Podcast

Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(265)

16. Mike Novotny, Founder and CEO, Medrio

16. Mike Novotny, Founder and CEO, Medrio

Mike Novotny is the founder and CEO of Medrio. Mr. Novotny applies 20 years of experience in research and software to his eClinical SaaS vision. Prior to founding Medrio, Mr. Novotny was president of ...

3 Jun 202034min

15. David Mace, Co-Founder and CEO, SwiftScale Biologics

15. David Mace, Co-Founder and CEO, SwiftScale Biologics

David Mace is the Co-founder & CEO of SwiftScale Biologics, a life sciences startup based in San Francisco, California. SwiftScale Biologics accelerates time to market for protein drugs by turning a l...

27 Mai 202029min

14. David Bates, PhD, Co-Founder, Linus Health

14. David Bates, PhD, Co-Founder, Linus Health

David Bates is a scientist, inventor, investor, and entrepreneur. He has co-founded several companies including Linus Health and Bode. He is a founding partner of Tamarisc Ventures and serves on the b...

20 Mai 202034min

13. Stephan Kontos, PhD, Co-Founder and CSO, Anokion

13. Stephan Kontos, PhD, Co-Founder and CSO, Anokion

Stephan is a co-Founder and Chief Scientific Officer at Anokion, bringing more than 15 years of research expertise in the fields of immunology, protein engineering, and platform technologies to the co...

13 Mai 202031min

12. Robert Gould, PhD, President & CEO, and Owen Wallace, PhD, CSO, Fulcrum Therapeutics

12. Robert Gould, PhD, President & CEO, and Owen Wallace, PhD, CSO, Fulcrum Therapeutics

Robert J. Gould joined Fulcrum as president and CEO at the time of the company’s launch in 2016, bringing over 30 years of experience to the role. Previously, he served as president and CEO of Epizyme...

4 Mai 202033min

11. Controllable cell and gene therapies, Paul Wotton, PhD, CEO, Obsidian Therapeutics

11. Controllable cell and gene therapies, Paul Wotton, PhD, CEO, Obsidian Therapeutics

Dr. Paul K. Wotton is the Chief Executive Officer at Obsidian Therapeutics. Obsidian is a biotechnology company pioneering controllable cell and gene therapies to deliver transformative outcomes for p...

27 Apr 202029min

10. Chris Murray, Sr. VP, Technical Operations, Blueprint Medicines

10. Chris Murray, Sr. VP, Technical Operations, Blueprint Medicines

Chris is Sr. Vice President, Technical Operations at Blueprint Medicines. He has over 25 years of commercial and clinical manufacturing experience in the biopharmaceutical industry and has been fortu...

26 Feb 202032min

9. The next frontier in cancer treatment: Foghorn Therapeutics and Chromatin Dysregulation

9. The next frontier in cancer treatment: Foghorn Therapeutics and Chromatin Dysregulation

Carl P. Decicco is a biopharmaceutical veteran with over 30+ years of experience in the industry. Over the course of his career, Carl has played a central role in the advancement of more than 200 comp...

23 Jan 202027min

Populært innen Vitenskap

fastlegen
romkapsel
jss
tingenes-tilstand
liberal-halvtime
sinnsyn
villmarksliv
forskningno
rekommandert
rss-paradigmepodden
fjellsportpodden
grunnstoffene
nordnorsk-historie
rss-nysgjerrige-norge
smart-forklart
rss-inn-til-kjernen-med-sunniva-rose
rss-rekommandert
tidlose-historier
psykopoden
rss-overskuddsliv